Full Press Release Details
Monte Rosa Therapeutics to Participate in the Jefferies London Healthcare Conference.
GLUE
Monte Rosa Therapeutics to Participate in the Jefferies London Healthcare Conference
Key Takeaway: Monte Rosa Therapeutics to Participate in the Jefferies London Healthcare Conference
Price reaction · baseline $9.13 (2024-11-12 close) · hit after-hours · clean, no other GLUE news in the window
day 0 close
-5.5%
day 1
-7.1%
day 3 · peak
-17.4%
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+67%
120-day peak, hindsight
Typical move
13.3%
average across 9 past catalysts
Cash runway
~41 mo
Minimal dilution risk
Lead asset
MRT-2359
Phase 2 · Castration-Resistant Prostate Cancer (CRPC)